![](/img/cover-not-exists.png)
Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial
Awal, Hassan B., Nandula, Seshagiri Rao, Domingues, Cleyton C., Dore, Fiona J., Kundu, Nabanita, Brichacek, Beda, Fakhri, Mona, Elzarki, Adrian, Ahmadi, Neeki, Safai, Shauna, Fosso, Magan, Amdur, RichVolume:
19
Journal:
Cardiovascular Diabetology
DOI:
10.1186/s12933-020-01046-z
Date:
December, 2020
File:
PDF, 1.76 MB
2020